AGILON HEALTH INC (AGL) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:AGL - US00857U1079 - Common Stock
0.6887 USD
-0.03 (-3.73%)
0.69 USD
+0 (+0.19%)
ChartMill assigns a Buy % Consensus number of 55% to AGL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 0.98. This target is 42.92% above the current price.
AGL was analyzed by 25 analysts. The buy percentage consensus is at 55. So analysts seem to be rather neutral about AGL.
In the previous month the buy percentage consensus was at a similar level.
AGL was analyzed by 25 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-06 | Barclays | Maintains | Underweight -> Underweight |
| 2025-11-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-20 | Bernstein | Downgrade | Outperform -> Market Perform |
| 2025-08-15 | Jefferies | Maintains | Hold -> Hold |
| 2025-08-14 | Baird | Maintains | Neutral -> Neutral |
| 2025-08-06 | Benchmark | Maintains | Buy -> Buy |
| 2025-08-06 | Barclays | Maintains | Underweight -> Underweight |
| 2025-08-06 | Citigroup | Downgrade | Buy -> Neutral |
| 2025-07-09 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-05-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-08 | Barclays | Maintains | Underweight -> Underweight |
| 2025-05-08 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-04-28 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2025-04-25 | Citigroup | Upgrade | Neutral -> Buy |
| 2025-04-15 | TD Cowen | Maintains | Hold -> Hold |
| 2025-04-15 | Baird | Maintains | Neutral -> Neutral |
| 2025-04-08 | Bernstein | Upgrade | Market Perform -> Outperform |
| 2025-03-21 | Needham | Reiterate | Hold -> Hold |
| 2025-02-26 | Citizens Capital Markets | Reiterate | Market Perform -> Market Perform |
| 2025-02-26 | Needham | Reiterate | Hold -> Hold |
| 2025-02-26 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-02-26 | Stifel | Maintains | Hold -> Hold |
| 2025-01-15 | Bernstein | Maintains | Market Perform -> Market Perform |
| 2025-01-10 | Needham | Reiterate | Hold -> Hold |
| 2025-01-10 | Citigroup | Upgrade | Sell -> Neutral |
| 2024-12-16 | Macquarie | Initiate | Neutral |
| 2024-12-11 | Bernstein | Initiate | Market Perform |
| 2024-11-19 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-11-13 | Citigroup | Maintains | Sell -> Sell |
AGILON HEALTH INC / AGL FAQ
What is the average price target for AGILON HEALTH INC (AGL) stock?
25 analysts have analysed AGL and the average price target is 0.98 USD. This implies a price increase of 42.92% is expected in the next year compared to the current price of 0.6887.
How do analysts rate AGILON HEALTH INC (AGL)?
The consensus rating for AGILON HEALTH INC (AGL) is 55.2 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts have analysed AGILON HEALTH INC (AGL)?
The number of analysts covering AGILON HEALTH INC (AGL) is 25.